ATE508734T1 - System zur vaginalen freisetzung - Google Patents

System zur vaginalen freisetzung

Info

Publication number: ATE508734T1
Authority: AT; Austria
Prior art keywords: core; release system; compartment; delivery system; drospirenone
Prior art date: 2007-11-22

Application number

AT07397043T

Other languages

English (en)

Inventor

Christine Talling

Antti Keinaenen

Svante Holmberg

Hannu Nikander

Original Assignee

Bayer Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-22

Filing date

2007-11-22

Publication date

2011-05-15

2007-11-22 Application filed by Bayer Oy filed Critical Bayer Oy

2011-05-15 Application granted granted Critical

2011-05-15 Publication of ATE508734T1 publication Critical patent/ATE508734T1/de

Links

METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 abstract 2
METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 abstract 2
229960004845 drospirenone Drugs 0.000 abstract 2
239000012528 membrane Substances 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000013543 active substance Substances 0.000 abstract 1
238000013270 controlled release Methods 0.000 abstract 1
229940011871 estrogen Drugs 0.000 abstract 1
239000000262 estrogen Substances 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
230000002035 prolonged effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicinal Preparation (AREA)

AT07397043T 2007-11-22 2007-11-22 System zur vaginalen freisetzung ATE508734T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP07397043A EP2062569B1 (de)	2007-11-22	2007-11-22	System zur vaginalen Freisetzung

Publications (1)

Publication Number	Publication Date
ATE508734T1 true ATE508734T1 (de)	2011-05-15

Family

ID=39273813

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07397043T ATE508734T1 (de)	2007-11-22	2007-11-22	System zur vaginalen freisetzung

Country Status (6)

Country	Link
EP (1)	EP2062569B1 (de)
AT (1)	ATE508734T1 (de)
DK (1)	DK2062569T3 (de)
ES (1)	ES2365552T3 (de)
PL (1)	PL2062569T3 (de)
PT (1)	PT2062569E (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI20095563A7 (fi) *	2009-05-20	2010-11-21	Bayer Schering Pharma Oy	Vaginaalinen antojärjestelmä
JP2019504021A (ja) *	2015-12-21	2019-02-14	バイエル・オーイュー	膣リングを製造する方法
CN110585246B (zh) *	2019-09-22	2020-06-02	深圳市多微生保健食品有限公司	一种阴道抑菌制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4469671A (en) *	1983-02-22	1984-09-04	Eli Lilly And Company	Contraceptive device
WO1997002015A1 (en) *	1995-07-04	1997-01-23	Akzo Nobel N.V.	Ring-shaped devices
US5972372A (en) *	1996-07-31	1999-10-26	The Population Council, Inc.	Intravaginal rings with insertable drug-containing core
US6063395A (en) *	1998-11-12	2000-05-16	Leiras Oy	Drug delivery device especially for the delivery of progestins and estrogens
AU2002313517B2 (en) *	2001-08-31	2007-09-06	Bayer Schering Pharma Oy	Drug delivery system
DE602004026173D1 (de) *	2003-04-29	2010-05-06	Gen Hospital Corp	Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
WO2005089723A1 (en) *	2004-03-24	2005-09-29	N.V. Organon	Drug delivery system based on polyethylene vinylacetate copolymers
EP1853272A1 (de) *	2005-02-03	2007-11-14	Duramed Pharmaceuticals, Inc.	Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür

2007
- 2007-11-22 PL PL07397043T patent/PL2062569T3/pl unknown
- 2007-11-22 PT PT07397043T patent/PT2062569E/pt unknown
- 2007-11-22 AT AT07397043T patent/ATE508734T1/de active
- 2007-11-22 EP EP07397043A patent/EP2062569B1/de not_active Not-in-force
- 2007-11-22 ES ES07397043T patent/ES2365552T3/es active Active
- 2007-11-22 DK DK07397043.6T patent/DK2062569T3/da active

Also Published As

Publication number	Publication date
EP2062569A1 (de)	2009-05-27
PT2062569E (pt)	2011-07-25
PL2062569T3 (pl)	2011-10-31
ES2365552T3 (es)	2011-10-06
DK2062569T3 (da)	2011-08-29
EP2062569B1 (de)	2011-05-11

Similar Documents

Publication	Publication Date	Title
EA201070639A1 (ru)	2010-10-29	Вагинальная система доставки
DE602005002745D1 (de)	2007-11-15	Medizinische vorrichtungen und verfahren zu ihrer herstellung
AR048185A1 (es)	2006-04-05	Sistema de entrega de farmacos constituido por uno o mas compartimentos, que comprende un compuesto progestagenico disuelto en un copolimero de polietileno acetato de vinilo termoplastico
WO2006127618A3 (en)	2007-02-22	Compressible gum based delivery systems for the release of ingredients
TW200735771A (en)	2007-10-01	Pesticide delivery system
DE60239554D1 (de)	2011-05-05	Medizinische vorrichtung zur abgabe von pflastern
WO2007037849A3 (en)	2008-01-24	Compositions and methods for the intraocular transport of therapeutic agents
MX2010014098A (es)	2011-03-21	Composiciones para aclarar el color de la piel.
ZA200701263B (en)	2009-03-25	Controlled release delivery system for bioo-active agents
WO2006084164A3 (en)	2006-11-23	Gastric retention and controlled release delivery system
EP2066304A4 (de)	2012-11-28	Systeme, verfahren und zusammensetzungen zur behandlung und verwendung eines gaumenpflasters
ATE401860T1 (de)	2008-08-15	Volumensparende arzneiform zur kontrollierten freisetzung
IL184448A0 (en)	2007-10-31	Pharmaceutically active phosphate binders, their manufacture, compositions containing them and their use
WO2008123582A1 (ja)	2008-10-16	テトラヒドロイソキノリン化合物
ATE537819T1 (de)	2012-01-15	Nutrazeutische zusammensetzungen zur behandlung von muskelschwund
ATE508734T1 (de)	2011-05-15	System zur vaginalen freisetzung
AR076588A1 (es)	2011-06-22	Sistema de liberacion vaginal
DE602005009812D1 (de)	2008-10-30	Abgabesystem für wirkstoff
WO2007108916A3 (en)	2007-12-27	Drug delivery composition and methods of making same using nanofabrication
CA2526954A1 (en)	2006-06-15	Antibiotics containing bone substitute material with sustained active substance release
EP1637167A3 (de)	2006-04-05	Neue einspritzbare Formulierungen enthaltend Progesteron
ATE406180T1 (de)	2008-09-15	Vorrichtung zur abgabe einer antimikrobiellen zusammensetzung
UA91337C2 (ru)	2010-07-26	Система доставки
FR2894143B1 (fr)	2008-05-02	Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
CL2007002563A1 (es)	2008-07-04	Compuestos derivados de fenoxi-fenil-acetamida; proceso de preparacion; composicion farmaceutica; kit farmaceutico; y uso como agente de diagnostico de imagenes.

Legal Events

Date

Code

Title

Description

2011-12-15

UEP

Publication of translation of european patent specification

Ref document number: 2062569

Country of ref document: EP